<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 07 Aug 2026 16:13:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  424B3      SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891183.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891183.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891183.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  424B3      SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891183.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891183.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891183.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  424B3      SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891155.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891155.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891155.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  424B3      SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891155.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891155.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891155.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  424B3      SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891100.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891100.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891100.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  424B3      SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891100.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891100.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891100.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  424B3      SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891053.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891053.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891053.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  424B3      SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891053.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891053.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26891053.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  10-Q       SOLIGENIX, INC.           For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SOLIGENIX%2C+INC.+++++++++++For%3A+Jun+30/26890992.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26890992.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SOLIGENIX%2C+INC.+++++++++++For%3A+Jun+30/26890992.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  10-Q       SOLIGENIX, INC.           For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SOLIGENIX%2C+INC.+++++++++++For%3A+Jun+30/26890992.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26890992.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SOLIGENIX%2C+INC.+++++++++++For%3A+Jun+30/26890992.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix, Inc. (SNGX) Tops Q2 EPS by 8c</title>
   <link>http://www.streetinsider.com/Earnings/Soligenix%2C+Inc.+%28SNGX%29+Tops+Q2+EPS+by+8c/26887614.html</link>
   <description>&lt;p&gt;Soligenix, Inc. (NASDAQ: SNGX) reported Q2 EPS of ($0.12), $0.08 better than the analyst estimate of ($0.20).&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Soligenix, Inc. (SNGX) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=SNGX&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Soligenix%2C+Inc.+%28SNGX%29+Tops+Q2+EPS+by+8c/26887614.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:47:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 7, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4747605-1&amp;amp;h=2213215732&amp;amp;u=http%3A%2F%2Fwww.soligenix.com%2F&amp;amp;a=Soligenix%2C+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix, Inc.&lt;/span&gt;&lt;/a&gt; (Nasdaq: SNGX) (&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix&lt;/span&gt; or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended &lt;chron&gt;June 30, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
             </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012003</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.59470868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 7, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4747605-1&amp;amp;h=2213215732&amp;amp;u=http%3A%2F%2Fwww.soligenix.com%2F&amp;amp;a=Soligenix%2C+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix, Inc.&lt;/span&gt;&lt;/a&gt; (Nasdaq: SNGX) (&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix&lt;/span&gt; or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended &lt;chron&gt;June 30, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
             </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012003</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.59470868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 7, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4747605-1&amp;amp;h=2213215732&amp;amp;u=http%3A%2F%2Fwww.soligenix.com%2F&amp;amp;a=Soligenix%2C+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix, Inc.&lt;/span&gt;&lt;/a&gt; (Nasdaq: SNGX) (&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix&lt;/span&gt; or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended &lt;chron&gt;June 30, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
             </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012003</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.59470868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 7, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4747605-1&amp;amp;h=2213215732&amp;amp;u=http%3A%2F%2Fwww.soligenix.com%2F&amp;amp;a=Soligenix%2C+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix, Inc.&lt;/span&gt;&lt;/a&gt; (Nasdaq: SNGX) (&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix&lt;/span&gt; or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended &lt;chron&gt;June 30, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
             </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012003</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.59470868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/PRNewswire/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 7, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4747605-1&amp;amp;h=2213215732&amp;amp;u=http%3A%2F%2Fwww.soligenix.com%2F&amp;amp;a=Soligenix%2C+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix, Inc.&lt;/span&gt;&lt;/a&gt; (Nasdaq: SNGX) (&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix&lt;/span&gt; or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended &lt;chron&gt;June 30, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
             </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012003</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.59470868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/PRNewswire/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 7, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4747605-1&amp;amp;h=2213215732&amp;amp;u=http%3A%2F%2Fwww.soligenix.com%2F&amp;amp;a=Soligenix%2C+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix, Inc.&lt;/span&gt;&lt;/a&gt; (Nasdaq: SNGX) (&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix&lt;/span&gt; or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended &lt;chron&gt;June 30, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
             </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012003</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.59470868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/PRNewswire/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 7, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4747605-1&amp;amp;h=2213215732&amp;amp;u=http%3A%2F%2Fwww.soligenix.com%2F&amp;amp;a=Soligenix%2C+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix, Inc.&lt;/span&gt;&lt;/a&gt; (Nasdaq: SNGX) (&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix&lt;/span&gt; or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended &lt;chron&gt;June 30, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
             </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012003</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.59470868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/PRNewswire/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 7, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4747605-1&amp;amp;h=2213215732&amp;amp;u=http%3A%2F%2Fwww.soligenix.com%2F&amp;amp;a=Soligenix%2C+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix, Inc.&lt;/span&gt;&lt;/a&gt; (Nasdaq: SNGX) (&lt;span value=&quot;NASDAQ-SMALL:SNGX&quot; idsrc=&quot;xmltag.org&quot; &gt;Soligenix&lt;/span&gt; or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent updates and financial results for the quarter ended &lt;chron&gt;June 30, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
             </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Soligenix+Announces+Recent+Updates+and+Second+Quarter+2026+Financial+Results/26887521.html</guid>
   <pubDate>Fri, 07 Aug 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012003</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.59470868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  ARS        SOLIGENIX, INC.           For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++ARS++++++++SOLIGENIX%2C+INC.+++++++++++For%3A+Dec+31/26857992.html</link>
   <description>si-local-file:///var/storage/secattach/20260803/26857992.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++ARS++++++++SOLIGENIX%2C+INC.+++++++++++For%3A+Dec+31/26857992.html</guid>
   <pubDate>Mon, 03 Aug 2026 16:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  ARS        SOLIGENIX, INC.           For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++ARS++++++++SOLIGENIX%2C+INC.+++++++++++For%3A+Dec+31/26857992.html</link>
   <description>si-local-file:///var/storage/secattach/20260803/26857992.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++ARS++++++++SOLIGENIX%2C+INC.+++++++++++For%3A+Dec+31/26857992.html</guid>
   <pubDate>Mon, 03 Aug 2026 16:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26857864.html</link>
   <description>si-local-file:///var/storage/secattach/20260803/26857864.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26857864.html</guid>
   <pubDate>Mon, 03 Aug 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    SOLIGENIX, INC.                      </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26857864.html</link>
   <description>si-local-file:///var/storage/secattach/20260803/26857864.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++SOLIGENIX%2C+INC.++++++++++++++++++++++/26857864.html</guid>
   <pubDate>Mon, 03 Aug 2026 16:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  DEF 14A    SOLIGENIX, INC.           For: Sep 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++SOLIGENIX%2C+INC.+++++++++++For%3A+Sep+17/26857766.html</link>
   <description>si-local-file:///var/storage/secattach/20260803/26857766.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++SOLIGENIX%2C+INC.+++++++++++For%3A+Sep+17/26857766.html</guid>
   <pubDate>Mon, 03 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
  <item>
   <title>Form  DEF 14A    SOLIGENIX, INC.           For: Sep 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++SOLIGENIX%2C+INC.+++++++++++For%3A+Sep+17/26857766.html</link>
   <description>si-local-file:///var/storage/secattach/20260803/26857766.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++SOLIGENIX%2C+INC.+++++++++++For%3A+Sep+17/26857766.html</guid>
   <pubDate>Mon, 03 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.01584314</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNGX</category>
   	  </item>
 </channel>
</rss>
